Lisa von Moltke - Feb 3, 2023 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role: Executive Vice President and Chief Medical Officer
Signature: /s/ Thomas J. DesRosier, attorney-in-fact for Lisa von Moltke
Stock symbol: MCRB
Transactions as of: Feb 3, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/7/2023, 04:48 PM
Previous filing: Jan 19, 2023
Next filing: Jun 5, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MCRB	Restricted Stock Units	Award	$0	+47.5K		$0.00	47.5K	Feb 3, 2023	Common Stock	47.5K		Direct	F1, F2
transaction	MCRB	Stock Option (Right to Buy)	Award	$0	+95K		$0.00	95K	Feb 3, 2023	Common Stock	95K	$5.50	Direct	F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2	The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter.
F3	The option will vest as to 25% of the shares on February 3, 2024. The remainder of the shares will vest in 12 equal quarterly installments thereafter.

Remarks:

Executive Vice President and Chief Medical Officer